Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SK Holdings Co. Ltd.

www.sk.com

Latest From SK Holdings Co. Ltd.

Conditions Converging For More M&A In Korean Pharma, Biotech

Merger and acquisition deals in South Korea’s pharma/biotech sector have remained relatively few compared to other countries, but several factors are now pointing to a possible increase in activity as pharma and biotech firms hunt for new technologies and growth. 

South Korea M & A

SK Acquires AMPAC, On Track To Meet Global Contract Manufacturing Ambitions

With the acquisition of US-based contract development and manufacturing organization AMPAC Fine Chemicals, SK has added the US production base to its European and Korean production facilities, placing it on track to becoming a top global CDMO player with annual production capacity of about 1.6 million liters.

South Korea US States

SK Acquires BMS Irish Plant To Support Global CMO Leadership Ambitions

SK Biotek's acquisition of BMS's small molecule API manufacturing plant in Ireland underlines South Korean conglomerate SK Group’s stepped up efforts to grow its biotech and pharma business. The move is in line with SK Biotek's plan to sharply raise revenue and corporate value in the coming years, and the CMO is also considering additional acquisitions or collaborations.

Commercial Manufacturing

New Active Substance Launches Declined Again In 2016

2016 witnessed a second straight year of decline in the number of new active substance launches worldwide, but trend data show that this hard measure of R&D productivity was still healthy compared with industry's performance during the first decade of the century.

Research & Development Companies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • SK Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • SK Holdings Co. Ltd.
  • Senior Management
  • Tae-Won Chey, Chmn. & CEO
    Heon-Cheol Shin, Pres.
  • Contact Info
  • SK Holdings Co. Ltd.
    Phone: (82) 2 2121 5114
    99 Seorin-Dong
    Jongru-gu
    Seoul 110-110,
    South Korea
UsernamePublicRestriction

Register